Evercore ISI Removes on Sensata Technologies (ST) From Tactical Outperform List.
Get Alerts ST Hot Sheet
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Evercore ISI analyst Amit Daryanani reiterated an In Line rating and $46.00 price target on Sensata Technologies (NYSE: ST).
The analyst comments "ST reported Sep-qtr results of $1,020M/$0.85 vs. street at $1,004M/$0.85 as the company saw 7% top-line growth and operating margins came in at 19.4% (~50bps uplift q/q). From a revenue perspective there were several moving parts - ST noted 650bps of content growth (above LT range of 400-600bps), market growth of 10.6%, M&A contribution of 3.3% offset by inventory adjustments (10%, $20M impact) and f/x headwind of 3.3%. While ST maintained a positive outlook for the Dec-qtr and potentially beyond, they did note signs of macro softness that is starting to impact inventory levels and potentially end-demand. For Dec-qtr they provided a guide that largely brackets street expectations at $1,000M/$0.88 at the midpoint, implying EBIT margins getting to 19.9% (+50bps q/q). For CY23, ST refrained from providing a formal guide, but we would note – content growth should be at the high-end of 400- 600bps, f/x will be a 300bps revenue and $0.11 EPS headwind. Inventory wind-down remains a key question ($50M, ~100bps headwind) and underlying auto production (IHS @ 3%)."
For an analyst ratings summary and ratings history on Sensata Technologies click here. For more ratings news on Sensata Technologies click here.
Shares of Sensata Technologies closed at $39.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sensata Technologies (ST) PT Raised to $56 at Barclays
- Freedom Broker Upgrades Garrett Motion (GTX) to Buy
- Regeneron Pharma (REGN) PT Raised to $1,020 at Raymond James
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Evercore Tactical Outperform ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share